EMA To Track Monkeypox Medicines Stock & Boost Emergency Task Force Output
Executive Summary
The European Medicines Agency is taking more actions to tackle monkeypox now that the disease has been declared a public health emergency.
You may also be interested in...
EU, UK & Brazil Take Steps To Boost Access To Monkeypox Vaccines
Regulators in the EU and the UK are exploring the intradermal use of monkeypox vaccine as a dose-sparing measure to stretch out scarce supplies, while Brazil is to waive the registration requirements for imported vaccines and therapeutics for monkeypox.
Cipla Uncorks Peptide Injectables Pipeline
Cipla readies scale-up in peptide injectables with five filings in the US and gears for upcoming high-value launches for generic versions of Advair, Revlimid and Abraxane. The company is also exploring partnering opportunities for monkeypox.
Cipla Uncorks Peptide Injectables Pipeline, Eyes Partnering For Monkeypox
Cipla readies scale up in peptide injectables with five filings in the US and gears for upcoming high value launches for generic versions of Advair, Revlimid and Abraxane. The company is also exploring partnering opportunities for monkeypox.